
Dapafyzin 5 Tablet
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dapafyzin 5 Tablet
Dapalin 5mg tablets are indicated as monotherapy or in combination regimens for managing type 2 diabetes. Their action lowers elevated blood glucose, mitigating the risk of associated severe complications, including cardiovascular events. Dapalin 5mg may be administered with or without food, consistently at the same time each day, as prescribed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation can elevate blood sugar, potentially leading to serious consequences such as renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, physical activity, and weight management, as directed by your doctor. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Excessive fluid loss is possible; adequate hydration is crucial to avoid dehydration. Practicing good hygiene can help reduce the likelihood of genital fungal infections. Prior to commencing treatment, discuss any pre-existing kidney or liver conditions, urinary tract issues, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption during treatment to minimize potential side effect occurrences. Regular blood glucose monitoring is essential throughout treatment.
Uses of Dapafyzin 5 Tablet
Managing type 2 diabetes
Major Benefits of Dapafyzin 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Dapafyzin 5mg tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Dapafyzin 5 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapafyzin 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapafyzin 5 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
How Dapafyzin 5 Tablet works:
Dapafyzin 5mg tablets are used to treat diabetes. Their mechanism of action involves eliminating surplus glucose via urinary excretion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapafyzin 5 Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapafyzin 5 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapafyzin 5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Dapafyzin 5 Tablet is likely inadvisable for individuals with kidney impairment and should be omitted. Seek medical advice.
LiverSAFE IF PRESCRIBED
Dapafyzin 5mg tablets are suitable for patients with hepatic impairment. No alteration of the Dapafyzin 5mg tablet dosage is necessary.
What if you forget to take Dapafyzin 5 Tablet :
Should you forget to take your Dapafyzin 5 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapafyzin 5 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
